Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fleischhauer

Showing results (491-500 of 529) with videos related to

Pageof 53
Sort By:
Bone Marrow Transplantation|April 19, 2018
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWPRaffaella Greco, Fabio Ciceri, Maddalena Noviello, et al.
Nature|November 24, 2022
MYC multimers shield stalled replication forks from RNA polymeraseDaniel Solvie, Apoorva Baluapuri, Leonie Uhl, et al.
Leukemia|November 6, 2014
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantationL Crucitti, R Crocchiolo, C Toffalori, et al.
Cell|January 23, 2026
MYC binding to nascent RNA suppresses innate immune signaling by R-loop-derived RNA-DNA hybridsLeonie Uhl, Amel Aziba, Sinah Löbbert, et al.
Frontiers in Immunology|August 4, 2023
Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progressionMaria Rafaeva, Adina R D Jensen, Edward R Horton, et al.
Blood|July 23, 2008
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantationLuca Vago, Barbara Forno, Maria Pia Sormani, et al.
Haematologica|March 5, 2026
Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenibRadwan Massoud, Sarah Flossdorf, Franziska Hanke, et al.
Bone Marrow Transplantation|April 8, 2026
Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignanciesAndrea Gantner, Svenja Labuhn, Daniel Fürst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2018
Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters MostBronwen E Shaw, Brent R Logan, Stephen R Spellman, et al.
The New England Journal of Medicine|July 31, 2009
Loss of mismatched HLA in leukemia after stem-cell transplantationLuca Vago, Serena Kimi Perna, Monica Zanussi, et al.
Pageof 53

Showing results (491-500 of 529) with videos related to

Sort By:
Pageof 53
Bone Marrow Transplantation|April 19, 2018
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWPRaffaella Greco, Fabio Ciceri, Maddalena Noviello, et al.
Nature|November 24, 2022
MYC multimers shield stalled replication forks from RNA polymeraseDaniel Solvie, Apoorva Baluapuri, Leonie Uhl, et al.
Leukemia|November 6, 2014
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantationL Crucitti, R Crocchiolo, C Toffalori, et al.
Cell|January 23, 2026
MYC binding to nascent RNA suppresses innate immune signaling by R-loop-derived RNA-DNA hybridsLeonie Uhl, Amel Aziba, Sinah Löbbert, et al.
Frontiers in Immunology|August 4, 2023
Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progressionMaria Rafaeva, Adina R D Jensen, Edward R Horton, et al.
Blood|July 23, 2008
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantationLuca Vago, Barbara Forno, Maria Pia Sormani, et al.
Haematologica|March 5, 2026
Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenibRadwan Massoud, Sarah Flossdorf, Franziska Hanke, et al.
Bone Marrow Transplantation|April 8, 2026
Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignanciesAndrea Gantner, Svenja Labuhn, Daniel Fürst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2018
Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters MostBronwen E Shaw, Brent R Logan, Stephen R Spellman, et al.
The New England Journal of Medicine|July 31, 2009
Loss of mismatched HLA in leukemia after stem-cell transplantationLuca Vago, Serena Kimi Perna, Monica Zanussi, et al.
Pageof 53